CSF substance P immunoreactivity in affective disorders

Wade H. Berrettini, David R. Rubinow, John I. Nurnberger, Susan Simmons-Alling, Robert M. Post, Elliot S. Gershon

Research output: Contribution to journalArticle

72 Scopus citations

Abstract

CSF substance P immunoreactivity was determined in a group of inpatient controls and acutely manic, euthymic, or depressed unmedicated unipolar and bipolar subjects; a second outpatient group of euthymic bipolar patients (on and off lithium) and normal volunteers was also studied. No group differences and no lithium effects were detected. CSF that was allowed to stand at room temperature for brief periods and then was refrozen contained elevated levels of the immunoreactive substance P, an observation that may account for a previous report of elevated CSF substance P immunoreactivity in psychiatric disorders.

Original languageEnglish (US)
Pages (from-to)965-970
Number of pages6
JournalBiological psychiatry
Volume20
Issue number9
DOIs
StatePublished - Sep 1985

ASJC Scopus subject areas

  • Biological Psychiatry

Fingerprint Dive into the research topics of 'CSF substance P immunoreactivity in affective disorders'. Together they form a unique fingerprint.

  • Cite this

    Berrettini, W. H., Rubinow, D. R., Nurnberger, J. I., Simmons-Alling, S., Post, R. M., & Gershon, E. S. (1985). CSF substance P immunoreactivity in affective disorders. Biological psychiatry, 20(9), 965-970. https://doi.org/10.1016/0006-3223(85)90193-3